Stroke prevention: Age alone does not rule out warfarin

MOspace/Manakin Repository

Breadcrumbs Navigation

Stroke prevention: Age alone does not rule out warfarin

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/5406

[-] show simple item record

dc.contributor.author Schumann, Sarah-Anne en
dc.contributor.author Ewigman, Bernard en
dc.date.accessioned 2010-02-15T15:07:21Z en
dc.date.available 2010-02-15T15:07:21Z en
dc.date.issued 2007-11 en
dc.identifier.citation Journal of Family Practice, 56(11) 2007: 902-906. en
dc.identifier.uri http://hdl.handle.net/10355/5406 en
dc.description.abstract Warfarin is as safe as aspirin and more effective for stroke prevention in elders with atrial fibrillation. Strength of recommendation (SOR) A: Well-designed randomized controlled trial of elderly patients in the primary care setting, consistent with findings from prior RCTs. en
dc.language.iso en_US en
dc.publisher Family Physicians Inquiries Network en
dc.relation.ispartof Priority Updates to Research Literature (PURLs) en
dc.source.uri http://data.memberclicks.com/site/fpin/61112007%20Warfarin%20and%20stroke.pdf en
dc.subject cardiovascular prevention en
dc.subject hemorrhage risk en
dc.subject anticoagulant en
dc.subject.lcsh Warfarin en
dc.subject.lcsh Cerebrovascular disease -- Prevention en
dc.subject.lcsh Aspirin -- Therapeutic use en
dc.title Stroke prevention: Age alone does not rule out warfarin en
dc.type Article en
dc.relation.ispartofcommunity University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network


This item appears in the following Collection(s)

[-] show simple item record